Article
Effects of arginine vasopressin on human anxiety and associations with sex, dose, and V1a-receptor genotype.
Psychopharmacology - 1 Jun 2024
Thompson R R, Price D, Burris D, Cloutier A, Rilling J K
Abstract excerpt
RATIONALE: Arginine vasopressin (AVP) has dose- and sex-specific effects on social behavior, and variation in social responses is related to variation in the V1a receptor gene in animals. Whether such complexity also characterizes AVP effects on anxiety in humans, or whether V1a genotype is related to anxiety and/or AVP's ability to affect it, remains to be determined. OBJECTIVE: To test if AVP has dose-dependent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
